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Abstract
Intratumoral genetic heterogeneity may impact disease outcome. Gold standard for dissecting
clonal heterogeneity are single-cell analyses. Here, we present an efficient workflow based on
an advanced Single-Cell Printer (SCP) device for the study of gene variants in single cancer
cells. To allow for precise cell deposition into microwells the SCP was equipped with an auto-
matic dispenser offset compensation, and the 384-microwell plates were electrostatically neu-
tralized. The ejection efficiency was 99.7% for fluorescent beads (n = 2304) and 98.7% for
human cells (U-2 OS or Kasumi-1 cancer cell line, acute myeloid leukemia [AML] patient; n =
150). Per fluorescence microscopy, 98.8% of beads were correctly delivered into the wells. A
subset of single cells (n = 81) was subjected to whole genome amplification (WGA), which
was successful in all cells. On empty droplets, a PCR on LINE1 retrotransposons yielded no
product after WGA, verifying the absence of free-floating DNA in SCP-generated droplets.
Representative gene variants identified in bulk specimens were sequenced in single-cell
WGA DNA. In U-2 OS, 22 of 25 cells yielded results for both an SLC34A2 and TET2 mutation
site, including cells harboring the SLC34A2 but not the TET2 mutation. In one cell, the TET2
mutation analysis was inconclusive due to allelic dropout, as assessed via polymorphisms
located close to the mutation. Of Kasumi-1, 23 of 33 cells with data on both the KIT and TP53
mutation site harbored both mutations. In the AML patient, 21 of 23 cells were informative for
a TP53 polymorphism; the identified alleles matched the loss of chromosome arm 17p. The
advanced SCP allows efficient, precise and gentle isolation of individual cells for subsequent
WGA and routine PCR/sequencing-based analyses of gene variants. This makes single-cell
information readily accessible to a wide range of applications and can provide insights into
clonal heterogeneity that were indeterminable solely by analyses of bulk specimens.
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Introduction
Intratumoral clonal heterogeneity may impact treatment response to chemotherapy or targeted
therapies and hence the outcome of cancer patients [1,2]. Information on gene mutations
derived from next generation sequencing (NGS) of bulk cell populations has been increasingly
used to gain insights into the clonal heterogeneity of malignancies. However, this bioinformati-
cally inferred data may only give an approximation of the definite clonal architecture. Single-
cell genotyping is necessary to verify the co-existence of mutations in a cell and to derive reli-
able information about the clonal architecture and evolution of a disease.
Genetic information on the single-cell level has becomemore accessible in the recent years.
This led to several studies which revealed deeper insights into the clonal architecture and evo-
lution of various types of solid cancers and leukemias, all of which highlighted the importance
of single-cell analyses [3–10]. As we and others have shown for acute myeloid leukemia
(AML), single-cell sequencing is particularly useful for verifying the clonal architecture con-
cluded fromNGS data and for resolving the clonal assignment of mutations when NGS pro-
vides ambiguous or complex clonal architectures [6–9].
Prerequisites for accurate single-cell analyses are the efficient isolation of cells from the bulk
sample and their precise deposition into reaction vessels for downstream analyses. Various
methods for single-cell isolation have been developedwhich are more or less suitable depend-
ing on the downstream application [11,12]. Among the most frequently used approaches is
fluorescence-activated cell sorting (FACS) which allows for high throughput isolation of single
cells [13]. However, FACS does not provide a direct proof that truly a single cell was isolated;
moreover, the integrity of the cells may be compromised by the shear forces inherent to the sys-
tem. More recently, various microfluidic approaches have been introduced such as hydrody-
namic cell trapping as utilized by Fluidigm´s C1 system [14]. However, these are limited in
their flexibility of applications due to a determined chip design. In addition to such automated
methods, single cells can be also picked manually with high precision by a microscope-assisted
device but only at limited numbers.
The Single-Cell Printer (SCP), that we developed and that was used in the present study, is
capable of isolating and depositing single cells with high viability rates in a label-free and non-
contact manner [15] and has been previously used for single-cell PCR on human B-cells [16].
Here, we further improve the droplet placement of the SCP to facilitate precise cell deposition
into the center of the wells of standard 384-microwell plates. Furthermore, we study gene
mutations and polymorphisms in cancer cells using routine PCR and Sanger sequencing after
whole genome amplification (WGA) in order to evaluate the co-occurrenceof mutations in
individual cells and the clonal genetic architecture.
Materials and Methods
Cell lines and patient sample
The osteosarcoma-derived cell line U-2 OS (LINTERNATM U-2 OS) was received from Inno-
prot (No. P20116; Derio, Spain) and cultured in DMEM/F12-Hammedium plus 10% FBS, 1%
penicillin/streptomycin and 10 μg/ml puromycin in a humidified 5% CO2 atmosphere; for har-
vesting, cells were trypsinized.The AML-derived cell line Kasumi-1 was received from the
research group of Michael Lübbert (University of Freiburg) who obtained it from DSMZ (No.
ACC 220; Braunschweig, Germany); the cells were cultured in RPMImedium plus 10% FBS
and 1% penicillin/streptomycin in a humidified 5% CO2 atmosphere. Furthermore, peripheral
bloodmononuclear cells (PBMCs) of a patient with AML were used (metaphase karyotype:
90–91, XXYY, -2, -5, +13x2, add(17)(p11), -21x2[cp8], 46,XY[3]; interphase fluorescence in
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situ hybridization (FISH): 90% of cells had 3 signals for 17p13). Written informed consent was
obtained from the patient prior to sampling. Sampling and research were approved by the eth-
ics committee of the University Freiburg on 13. June 2013 and under the reference no. 464/11.
At the time of sampling, the peripheral blood of the patient contained 82% blasts as assessed by
cytomorphology. The blood sample was enriched for mononuclear cells through Ficoll-Hypa-
que and cryopreserveduntil use. Genomic DNA was extracted from the bulk samples using the
AllPrep DNA/RNA Kit (Qiagen).
Sample preparation and single-cell printing
In principle, the SCP was used as describedbefore [15]. Prior to cell printing in the current
study, the cells were re-suspended in PBS to yield a final concentration between 105 and 106
cells/ml. For each experiment, a new sterile cartridgewith a 40 μm nozzle was filledwith 30 μl
sample and mounted on the SCP. The piezo stroke length was set to 10 μm and the downstroke
velocity was set to 140 +/- 10 μm/s to achieve stable droplets. Individual cells were printed into
the wells of a standard 384-microwell PCR plate. Electrostatic charges on the plates were neu-
tralizedwith an ionizing air blower (minION2, SIMCO-ION, The Netherlands). Sample load-
ing and instrument preparation took on average approximately 5 minutes.
Calculation of the dispenser offset
In order to compensate for dispenser offset, reference droplets were dispensed on a hydropho-
bic-coated glass slide that is imaged by a digital camera (DFM 72BUC02-ML, The Imaging
Source, Germany) from below. The position of the droplet was then calculated from the image
data by the SCP software using the.NET openCVwrapper Emgu CV. This fully automated pro-
cess was carried out prior to the cell deposition and each time the offset was taken from the
mean of three subsequently dispensed droplets. After completion of the single-cell deposition
the dispenser offset was assessed again for comparison with the offset measured at the start of
the experiment. By this means, a drift in the dispenser offset that could potentially occur during
the experiment can be automatically detected.However, in this study, we experiencedno sig-
nificant drift that would compromise the precision of cell deposition into the microwells.
Metrics for the single-cell isolation performance
Single-cell isolation performance of the SCP was characterized using two measures. The ejec-
tion efficiency is defined as the number of single beads or cells ejected from the nozzle divided
by the total number of printing events targeted to the microwell plate. The ejection efficiency is
determined from the SCP images and is therefore independent of the target (e.g well). The
deposition efficiencyquantifies the number of single beads or cells correctly delivered to the
bottom of the microwells. Since single fluorescent cells cannot always be clearly visualized on
the microwell bottoms due to auto-fluorescence caused by the rough well surface, we used
high-intensity fluorescent beads (Kisker Biotech, Germany) to determine the deposition
efficiency.
Detection of nucleotide variants in the bulk specimens
Candidate gene mutations in the cell lines were selected via the COSMICmutation database
[17] and confirmed by Sanger sequencing (U-2 OS, Kasumi-1) or MiSeq-based targeted NGS
(Kasumi-1) of bulk specimens. In the patient sample, variants were assessed by Sanger
sequencing. Variant allele frequencies (VAFs) in Kasumi-1 were derived fromNGS or
pyrosequencing.
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In the targeted NGS assay, 70 genes reported to be mutated in AML or other hematologic
cancers were analyzed by multiplexed amplicon resequencing (Agilent HaloPlex); sequencing
was performed on an IlluminaMiSeq platform using 2 x 250 bp paired-end reads [18]. Pyrose-
quencing was performed according to the manufacturer’s instruction using a PyroMark Q96
MD system.
CytoScan HD or Human SNP Array 6.0 arrays (Affymetrix)were performed on the bulk
samples. The data were analyzed using the ChromosomeAnalysis Suite (ChAS) software. For
the evaluation of copy number variations (CNVs), the normalized probe intensities for the A
and B alleles were summarized to calculate allelic signal values. The allelic difference was calcu-
lated as the difference between the signal of the A allele minus B allele, and standardized so
that an A allele genotype has a positive value and a B allele a negative value. The standardiza-
tion was based on median values for the allelic difference under different genotype configura-
tions determined by the reference set. The array data are deposited at http://www.ebi.ac.uk/
arrayexpress/ (Acc. E-MTAB-4950). In addition, publically available SNP Array 6.0 data
(NCBI GEO database acc. GSM879223) were used to identify heterozygous single nucleotide
polymorphisms (SNPs) in U-2 OS (see below).
Whole-genome amplification of single-cell DNA
The printed cells were lysed and the DNA of each cell was amplified by WGA using the
REPLI-g Single Cell Kit (Qiagen), which is based on multiple displacement amplification. The
manufacturer’s protocol was modified in terms of a four-fold reduction of all reagents resulting
in a final reaction volume of 12.5 μl. The DNA yield was assessed by Qubit fluorometric quan-
titation (Thermo Fisher Scientific) according to the manufacturer’s protocol. In addition, a
multiplex PCR on repetitive LINE1 retrotransposons was used to evaluate the DNA after the
WGA. This PCR generates specific products of different sizes irrespective of whether specific
genomic regions were amplified better or worse by theWGA, and are thus over- or underrep-
resented. The LINE1 primers are provided in S1 Table.
Single-cell genotyping
For single-cell genotyping, the WGA DNA from the individual cells was subjected to PCR and
Sanger sequencing of the selected variant loci. As WGA can lead to the preferential amplifica-
tion of one allele and allelic dropout (ADO), we also sequenced SNPs that were identified by
CNV array to be heterozygous in the bulk sample and located in close genomic proximity to
the respectivemutation loci. If, in a single cell, there was no mutated sequence at the mutation
site and the respective SNP not heterozygous, then ADOmay have occurred at the genomic
locus, and the mutation analysis was deemed to be inconclusive. The primers are provided in
S1 Table.
Results
The SCP and its implementation into the single-cell genotyping workflow
The original SCP principle has been previously described in detail [15]. Fig 1A–1C show the
SCP prototype that we used for the present study and the workflow for single-cell isolation and
analysis in the 384-well format: First, the cell suspension is pipetted into the disposable car-
tridge that consists of a milled plastic part and the microfluidic dispenser chip (Fig 1A). Next,
the cartridge is mounted on the printhead that comprises the piezo actuator driving the dis-
penser chip (Fig 1B). A microscopic vision systemmonitors the nozzle of the dispenser chip
and provides the image data for cell detection, classification and isolation (see below).
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Unwanted droplets are discarded via a vacuum shutter system. The printhead is mounted on a
three-axis robotic stage which allows precise deposition of single-cell encapsulating droplets
into microwells specified in the SCP software by the operator. Different from previous applica-
tions, in the present study, the SCP was used for the isolation of cancer cells and subsequent
cell lysis, WGA and molecular genetic analyses (Fig 1D).
Evaluation of the precision and efficiency of single-cell deposition
A prerequisite for the genetic analyses is the exact deposition of the single cell in the well, since
only then the cell lysis and WGA can be reliably performed, given the small reaction volumes.
Although the precision of the dispenser is sufficiently high to deposit single-cell encapsulat-
ing droplets into microwells, we observed that the droplet position within the well can vary. The
reason is a variation of the nozzle position due to the cartridge fabrication process and the fixa-
tion of the cartridge to the printhead. In order to deposit droplets accurately onto the well bot-
tom in an automated manner we designed a tool to compensate for such an offset by measuring
the droplet placement position before and during the cell isolation process. For this, droplets are
dispensed on a glass slide that is imaged by a digital camera attached to the microwell plate-
holder (Fig 2). The droplet position is extracted from the image data and the algorithm automat-
ically calculates the correct dispensing position to target the center of the microwells.
In addition, free-flying droplets can be deflectedby electrostatic forces, which occur due to
the electric charge that accumulates on both the droplet and plate. Thus, we used ionized air to
neutralize the electrostatic charging of the microwell plate.
In order to evaluate whether the SCP with the automatic dispense offset compensation and
the deionization deposits single droplets with high efficiency and precision, single 10 μm sized
green fluorescent latex beads as cell equivalents were printed into the wells of a 384-microwell
Fig 1. Single-cell genotyping workflow implementing the Single-Cell Printer. (A) The cell suspension is
filled into the sterile single-use cartridge. (B) The microwell plate holder is equipped with a camera to
automatically determine and adjust for the dispenser offset prior to cell printing (automatic offset
compensation, AOC). The dispenser with the mounted cartridge and the cell detection optics are part of the
printhead. (C) Total view of the SCP prototype that was used in this study. (D) Illustration of the workflow for
single-cell genotyping. Individual cells are isolated via the SCP. After cell lysis, the DNA is subjected to whole
genome amplification (WGA), which then can be used for routine molecular genetic analyses.
doi:10.1371/journal.pone.0163455.g001
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plate, and the ejection and deposition efficiencieswere assessed. The ejection efficiency (i.e.
truly a single bead has been ejected from the nozzle) was determined through the images auto-
matically stored by the SCP that show the nozzle before, during, and after the dispensation (Fig
3A–3E). The deposition efficiency (i.e. a single bead was successfully delivered to the bottom of
the well) was concluded from fluorescencemicroscopy images (Fig 3F).
Of the fluorescent beads, 1152 each were dispensed into three untreated or three deionized
384-well plates; this equaled a total number of 2304 beads. The overall single-bead ejection effi-
ciency was on average 99.7 ± 0.3%. The deposition efficiencydepended on whether the plate
was deionized or not. Without prior deionization, in only 20.7 ± 8.4% of the well bottoms a sin-
gle bead was detected, while after deionization 98.8 ± 1.5% of the beads were correctly delivered
(Fig 3G).
Following this workflow, a total of 150 single cells of different origins (U-2 OS, n = 40;
Kasumi-1, n = 44; AML patient, n = 66) were printed into deionized 384-well plates resulting
in a total single-cell ejection efficiencyof 98.7%. A subset of the printed cells of each specimen
was subjected to WGA and genotyping (as detailed below).
Whole genome amplification of single-cells
Single cells were subjected toWGA prior to downstreammolecular analysis. In order to mini-
mize the odds for contaminating DNA that would be co-amplified by theWGA, we worked
with DNA-free cartridges and plates and reduced the hands-on steps during cell isolation, lysis
and amplification. The success of theWGA was assessed by fluorometric quantitation of the
DNA, and a PCR on repetitive LINE1 transposons was used to control for the amplification of
human DNA in the samples and its absence in the no-template control.
Fig 2. Automatic dispenser offset compensation (AOC) by measuring droplet placement position
before / during the cell isolation process. (A) For this, droplets are dispensed on a glass slide that is
imaged by a digital camera. (B) The actual droplet position is extracted from the image data by image
processing with openCV. (C) displays the binary image after thresholding. The algorithm automatically
calculates the correct dispensing position to target the center of the microwell.
doi:10.1371/journal.pone.0163455.g002
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Of the 40 U-2 OS cells that were deposited into the deionizedmicrowells, 25 were subjected
to a WGA resulting in a median DNA yield of 3.8 μg (range, 3.5–5.5 μg) per cell (Fig 4A); the
PCR on the LINE1 transposons was positive in all samples (Fig 4B). Of Kasumi-1, 33 cells were
subjected to WGA, resulting in a median DNA yield of 14.3 μg (range, 8.6–20.8 μg) per cell,
and the LINE1 PCR was positive in all cells (S1 Fig). Among the 23 single cells from an AML
patient, the WGA resulted in a median DNA yield of 16.3 μg (range, 14.0–19.3 μg) per cell and
a positive LINE1 PCR in all cells (S2 Fig).
We also examined whether free-floatingDNA was present in the droplets generated by the
SCP. Such DNA, if amplified by theWGA, would hinder the genetic analyses of the single cells.
Therefore, empty droplets (n = 1, 3, and 10, respectively) from a suspension of Kasumi-1 cells
were printed into individual wells of a 384-well plate and then subjected toWGA. All empty
droplets yielded no product in the subsequent LINE1 PCR, while droplets containing single
Kasumi-1 cells were positive (S3 Fig).
Fig 3. Efficiency of single-cell ejection and deposition into microwells. Four consecutive images are
stored automatically for each printing event: (A-C) A cell (or bead as cell equivalent) is transported towards
the nozzle of the dispenser-chip, where it is detected and classified within a region of interest (ROI, green
area). Only if the object recognition meets predefined criteria in terms of size, roundness and singularity,
the droplet ejected from the nozzle will be targeted to the well. (D) A final image confirms the absence of the
cell in the nozzle after droplet ejection. The image series can be used to provide direct evidence that truly a
single cell was ejected. (E) shows an example for an image where two cells would enter the droplet. Such
droplets are automatically discarded by the vacuum suction. To evaluate the precision of the instrument,
2304 single fluorescent beads were printed into six 384-microwell plates. The images were evaluated to
determine the ejection efficiency (99.7%). (F) Correctly deposited beads (dashed circle) were visualized
by fluorescence microscopy of the well bottoms (1.2 mm in diameter). (G) The beads were correctly
delivered in an average of 98.8% of the wells if the microwell plate was electrostatically neutralized before
printing.
doi:10.1371/journal.pone.0163455.g003
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Fig 4. Single-cell whole genome amplification and sequencing of the U-2 OS cell line. (A) Bar diagram
displaying the WGA DNA yields from the individual U-2 OS cells and the respective controls, as measured by
QubitTM. (B) Agarose gel illustrating the differently sized products of the LINE1 multiplex PCR that was
performed on the WGA DNA of the individual U-2 OS cells. (C) Exemplary sequencing chromatograms of the
SLC34A2 and TET2 gene mutations in the cell bulk and individual cells. (D) Conclusions on the occurrence
of allelic dropout (ADO) through sequencing of single nucleotide polymorphisms (SNPs). SNPs rs1391438
Genotyping of Individual Cancer Cells
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Genotyping of single cancer cells
We sought to evaluate the applicability of the SCP for the isolation and genetic analyses of sin-
gle cancer cells. For this, we studied representative gene variants in U-2 OS, Kasumi-1 and the
PBMCs of a patient with AML.
U-2 OS harbors mutations in the SLC34A2 (ENST00000382051: c.1538G>T; p.R513L) and
TET2 genes (ENST00000380013: c.1394C>T; p.P465L) [17], both of which are of functional
relevance in cancers [19–21]. We confirmed the mutations in SLC34A2 and TET2 in the bulk
sample. In line with published data [17], the chromatograms suggested that the SLC34A2
mutation was homo- or hemizygous and the TET2 mutation heterozygous. From our CNV
array data, we concluded that the zygosity of the SLC34A2 mutation was due to the loss of het-
erozygosity (LOH) of the respective genomic region. In the 25 U-2 OS cells analyzed, the
SLC34A2 mutation was detected in 23 and the TET2 mutation in 19 cells (Figs 4C and 5A). In
one cell, the SLC34A2 PCR and, in another cell, both the SLC34A2 and TET2 PCR repeatedly
failed, which suggests insufficient amplification of the target region by theWGA. As expected
from the zygosity in the bulk, no cell with SLC34A2 wild-type sequence was detected. In con-
trast, TET2 wild-type sequence only was detected in 5 cells. These cells were evaluated for the
presence of ADO to allow conclusions regarding the co-occurrenceof mutations in the individ-
ual cells (see below).
and rs7655890 are located in close genomic proximity to the TET2 mutation and show heterozygous
patterns in the cell bulk (left). In the single U-2 OS cells B8 and C10, wild-type only is detected at the TET2
mutation site. The heterozygous patterns of the SNPs in B8 suggest true wild-type in TET2, while the
detection of only one allele of both SNPs in C10 suggest loss of the genomic region due to ADO. NTC: no-
template control, PTC: positive control.
doi:10.1371/journal.pone.0163455.g004
Fig 5. Summary of the genotyping results. (A) U-2 OS cell line, (B) Kasumi-1 cell line and (C) AML patient. Displayed are the nucleotides identified
by sequencing of the bulk specimens and the individual cells (annotated for example B1 or C1). Highlighted in red is the presence and in green the
absence of the respective mutated sequence. Highlighted in grey are inconclusive analyses either due to failed PCR (n.d., not determined) or the
likely occurrence of allelic dropout (*). For the gene mutation analyses, the clonal architecture concluded from the single-cell analyses is
schematically displayed.
doi:10.1371/journal.pone.0163455.g005
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Kasumi-1 harbors mutations in the tyrosine kinase KIT (ENST00000288135: c.2466T>A; p.
N822K) and the tumor suppressor TP53 (ENST00000269305: c.743G>A; p.R248Q) [17]. The
mutations in KIT and TP53 were confirmed by NGS in a Kasumi-1 bulk sample. As verified by
pyrosequencing, the VAF of the KIT mutation was 84.0% at median (range, 83.3–85.2%). The
overrepresentation of the mutated allele is due to the amplification of the KIT genomic region
[22,23]. The TP53 mutation was present with a VAF of 100% in line with an LOH of the chro-
mosome 17p region in the CNV array. The KIT mutation was detected in 30 and the TP53
mutation in 25 cells (Fig 5B). In the remaining cells, the KIT or TP53 PCR failed, most likely
due to an inefficient amplification of the respective regions by theWGA. No cell with KIT or
TP53 wild-type sequence only was detected.With regard to the co-occurrenceof the mutations,
the analyses yielded informative results for both mutations in 23 cells. All these cells harbored
both the KIT and TP53 mutation (Fig 5B).
In the PBMCs of a patient with AML, we assessed the potentially pathogenic non-synony-
mous SNP rs1042522 in TP53 (ENST00000269305: c.215C>G; p.P72R) [24,25]. We decided
for this approach since no C-allele was detectable by Sanger sequencing of the bulk specimen
and since, as indicated by FISH and CNV array, the AML harbored one or more clones with
loss of a chromosome 17p allele (including TP53; S4 Fig), and chromosomal loss of TP53 in
cancers preferentially affects the C-allele of rs1042522 [25]. Thus, we tested whether an ances-
tral C-allele would be still detectable in a subset of individual cells. Indeed, the TP53 PCR
yielded a product in 21 cells, in 5 of which the C-allele was detected (Fig 5C).
Evaluation of allelic dropout and co-occurrence of mutations in U-2 OS
As stated above, in 5 U-2 OS cells the TET2 wild-type sequence only was detected. To evaluate
whether the absence of TET2 mutations in these cells was due to ADO, we analyzed the SNPs
rs1391438 and rs7655890 (located 4,650 bp and 15,992 bp 5’ from the TET2 mutation, respec-
tively) in these cells; both SNPs were heterozygous in the bulk sample (Fig 4C). In one of the 5
cells, only one of the two alleles of each SNP was detected, which strongly suggests that ADO
has occurred at the genomic region that included the SNPs and TET2 mutation (Fig 4C). Thus,
we deemed the analysis of this one cell inconclusive. In the remaining 4 cells, both of the SNPs
were heterozygous, suggesting that WGA has successfully amplified both alleles (Fig 4C); this
makes it unlikely that the absence of the TET2 mutation in these cells was due to ADO. Thus,
we concluded that these 4 cells indeed lacked the TET2 mutation.
Thus, in terms of co-occurrence, our analyses yielded informative results for both mutation
sites in 22 cells. Of these, 18 cells harbored both the SLC34A2 and TET2 mutation while 4 har-
bored the SLC34A2 but not the TET2 mutation, which indicates clonal heterogeneity with
regard to TET2 mutated cells within the U-2 OS cell line (Fig 5A).
In Kasumi-1, no evaluation of ADOwas necessary since no cell with KIT or TP53 wild-type
sequence only was detected.
Discussion
Single-cell analyses are the gold standard for deciphering the genetic clonal architecture of
solid and blood cancers. Yet, current techniques most often assess gene mutations in the entire
population of malignant cells without taking into account that cells might differ genetically
from each other. Here, we assessed gene mutations and polymorphisms in bulk samples and
individual cancer cells, which were isolated using an improved version of the SCP.
We previously demonstrated that the SCP allows for the isolation and deposition of individ-
ual cells with minor impact on cell integrity [15]. The sterile single-use cartridges can be oper-
ated with sample volumes as low as 5 μl, have a minimal dead volume, and avoid cross-
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contamination, as they are the only part that is in contact with the sample. Moreover, the
image data that the SCP collects and stores during each experiment, allows for verification that
truly a single cell was ejected from the nozzle. Potential double-cell events (which did not occur
during this study) can be therefore excluded from downstream analysis without additional
imaging of the microwells. The images can be also used for interrogating basic morphological
properties such as size and roundness of the printed cell. In summary, the SCP provides the
required premises to isolate individual cells from even precious samples for subsequent molec-
ular analyses.
In order to allow accurate cell deposition, for the present study, we improved our established
SCP by an automated dispense positionmeasurement system which ensures that the droplets
are accurately dispensed onto the specified target positions without any additional user interac-
tion. The system also allows monitoring whether the dispenser delivers stable droplets
throughout the cell isolation process. This is a benefit compared to FACS devices, where man-
ual fine-tuning prior to cell isolation is required, including definition of the sorting parameters
(fluorescence intensity, forward and side scatter) or alignment of the plate-sorting unit to the
microwells.
The single-cell containing droplets that are ejected from the SCP are 160 pl in volume and
have velocities of typically 2 m/s. In case of spontaneous electrostatic droplet charging [26],
such droplets can be deflectedby electrostatic forces due to interaction with the substrate (i.e.
the microwell plate). In order to avoid such deflection the droplets or substrate need to be free
of electrostatic charge. Here, we successfully applied ionized air to neutralize the charging on
the plate. This resulted in droplet trajectories without significant deflection,which was verified
by the precise deposition of fluorescent beads onto the bottom of the microwells yielding a
deposition efficiencyof 98.8%. This is significantly higher than the single-cell trapping efficien-
cies that are frequently achieved with hydrodynamic cell trapping in microfluidic chips [14].
In the current study, we used the SCP for the isolation of individual cells of cancer cell lines
and a patient AML sample to study gene variants that we had detected in the respective bulk
specimens. For this, a total of 81 of the printed cells were subjected to WGA to generate suffi-
cient DNA for the genetic analyses. TheWGA was successful in all cells, and the DNA yields
were uniform and high across the cells isolated per SCP run. In addition, the four-fold reduc-
tion of WGA reagents, that we applied in our protocol, implied a profound reduction in costs.
The single-cell containing droplets that are ejected from the SCP are very small, as men-
tioned above; they are approximately 20x less in volume than the droplets typically produced
by FACS. This minimizes the possibility of free-floatingDNA in the medium that surrounds
the single cell. We nevertheless evaluated the presence of free-floating human DNA in the
droplets by printing empty droplets (i.e. not containing a cell, as verified by the SCP image
data) from a cell suspension and subjecting these droplets to WGA. While the LINE1 PCR
yielded products for the cell-containing droplets, it remained negative for all empty droplets.
This indicates that free-floating human DNA in the droplets is, if at all, a rare event, which
clearly improves the reliability of the single-cell data gained from SCP experiments.
An issue of WGA on single-cell DNA is the potential occurrence of ADO. This is of minor
importance if the wild-type allele is not amplified, since the mutation will still be detectable.
However, if the mutated allele is affected, then this can lead to false interpretation of a cell as
being wild-type in the respective gene. In order to control for ADO of the mutated allele, we
analyzed cases with the detection of wild-type only for SNPs that were heterozygous in the
bulk specimen and located in genomic proximity to the mutation site. If the SNPs were not het-
erozygous (i.e. lost one allele) in the single cell, then the mutated allele was deemed to be lost
by ADO. In U-2 OS, TET2 wild-type only was identified in 5 cells. Based on the SNP analyses
we concluded that 4 of the 5 cells indeed did not harbor the TET2 mutation (as both alleles of
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the SNPs were detected), while in one cell the TET2 mutated allele may have been lost due to
ADO (as only one allele of the SNPs was detected). This implies that SNP and mutation sites
are present in the sameWGA fragments. This is the more probable the closer the sites are
located to each other; ideally, they are covered by same PCR amplicon, which is rarely possible.
However, WGA fragments have an average product length of more than 10kb [9, 27]. Thus,
despite the residual uncertainty, the SNPs that we used were likely suitable to control for ADO
of the TET2 mutation site.
The analyses of the overall 81 single cells yielded 133 successful sequencing reactions and
allowed insights into the clonal genetic architecture of the samples.
Among the 22 U-2 OS cells with results for both the SLC34A2 and TET2 mutation, 18 cells
harbored both mutations and 4 harbored the SLC34A2 but not the TET2 mutation. This indi-
cates that U-2 OS consists of clones that are heterogeneous with regard to the TET2 mutation
status. Our findings are in line with the absence of SLC34A2 wild-type but presence of both
TET2 wild-type and mutated sequences in the bulk sample.
In the 33 Kasumi-1 cells, the TP53 PCR failed in 8 cells, likely since the respective region on
chromosome 17p did not amplify during theWGA, despite the overall success of theWGA in
these cells. The amplification failure of the TP53 region may be attributable to the LOH of the
17p arm in Kasumi-1, since in this case only one allelic copy (as opposed to two in a diploid
cell) serves as template for theWGA. Of the 23 cells with information on both KIT and TP53,
all cells harbored both mutations.
Among the 23 single cells of the AML patient, the analysis of the TP53 polymorphismwas
successful in 21 cells. In the bulk sample, the cytogenetic data indicated the loss of one copy of
the TP53 encoding chromosomal region, and no C-allele was detectable by Sanger sequencing.
Based on this and considering the poor sensitivity of Sanger sequencing, the ancestral genotype
in the TP53 SNP may have beenG/G or G/C. From the analyses we concluded that the ancestral
genotype was G/C and that the C-allele was affected by the chromosomal deletion. This is in line
with the observation that chromosomal loss of TP53 preferentially affects the C-allele [25,28].
In addition to previous reports by us and others [6–9] we here display examples on how
information at the single-cell level can complement and extend the genetic information derived
from bulk specimens. The single-cell genotyping allowed verifying the co-occurrenceof vari-
ants in a given cell, which is essential since only variants that co-exist in a cell can indeed
impact together on the biology of this cell. Moreover, the verification or falsification of the co-
occurrence of variants allowed conclusions regarding the clonal architecture and evolution.
We are aware that our study has limitations. The number of cancer samples, cells per sample
and mutations per cell that we analyzed is relatively small; the analyses of more cells and muta-
tions would allow a more profound insight into the possibilities and limitations of our tech-
nique as well as into the clonal architecture of the samples.
However, our study for the first time demonstrates how the SCP, that we had previously
established and the precision of which we have further improved for the present study, is used
to isolate individual cancer cells in a highly automated manner for molecular genetic analyses.
Of particular significance is that, on the cells isolated with the SCP, we obtained uniform and
high DNA amounts throughWGA and applied routine downstream gene analyses. These fea-
tures of the SCP and the prior identification of candidate variants in bulk specimens, which
then can be studied for co-occurrence in relatively few cells, also demonstrate how meaningful
results are obtained from single-cell genotyping at relatively low costs. The costs are indeed fur-
ther lowered as one SCP cartridge can be used for the isolation of any number of cells per sam-
ple. Although not yet routinely performed the clinical demand for single-cell genotyping, as
performed in our study, will likely increase, together with the use of NGS and targeted thera-
pies, and the accordingly increased focus on clonal architecture and evolution of cancer.
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In conclusion, we present an efficient workflow for the genetic analysis of individual cancer
cells using the SCP for automated cell isolation. Given the flexibility of the SCP and its
improved precision in cell deposition we were able to reliably use the instrument in combina-
tion with routine downstream genetic applications. In the future, we will combine the SCP
with robotic liquid handling for further assay automation, corroborate our workflow for use
with biopsies and explore the application of our workflow for NGS and the concurrent analyses
of genetic and epigenetic aberrations.
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